Cancer
Genetic Profiling of Non-Small Cell Lung Cancer at RUSH with Mary Jo Fidler, MD
Mary Jo Fidler, MD, is a thoracic oncologist and professor of Internal Medicine at RUSH University Medical Center. She is the Medical Oncology Section Chief in the RUSH Cancer Center and is the national principal investigator for the ADAURA trial, which is studying the effects of postoperative Osimertinib in resected EGFR+ lung cancer patients.
Lung Health
RUSH Respiratory Specialists Named ‘Top Doctors’
Chicago magazine list includes pulmonology, allergy and immunology specialists
Lung Health
Why Lung Cancer Screenings Are Essential
"It's the only way we have to catch lung cancer early"

Cancer
Linda’s Story: COVID, Then Cancer
A severe case of COVID-19 leads to a life-saving lung cancer diagnosis
Cancer
Screening Catches Chicago Firefighter's Lung Cancer
Thomas Magliano went to a screening on a whim. RUSH caught his cancer early.
Awards, Rankings and Recognitions
RUSH Earns Top Ratings From Society of Thoracic Surgeons
Three-star rating distinguishes RUSH cardiac and thoracic surgery programs as among the best in the nation
Cancer
Understanding Lung Cancer Screening
Rush physician Jennifer Earvolino, MD, explains how screenings work, who should get them

Cancer
Lung Screenings Begin in My Exam Room
Eligibility for cancer screening can be a 'wake-up call'
Cancer
Saving Lives With Lung Cancer Screening
A Rush screening manager on overcoming the stigma to help catch lung cancer early